Global Exosome Engineering Service 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06250112

Publication Date:

June 17, 2025

Pages:

106

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Exosome Engineering Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Exosome Engineering Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Exosome Engineering Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Exosome Engineering Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Exosome Engineering Service players cover Creative Biostructure, Everzom, System Biosciences, Creative Biolabs, LipExoGen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淓xosome Engineering Service Industry Forecast鈥� looks at past sales and reviews total world Exosome Engineering Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Exosome Engineering Service sales for 2025 through 2031. With Exosome Engineering Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exosome Engineering Service industry.
This Insight Report provides a comprehensive analysis of the global Exosome Engineering Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Exosome Engineering Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Exosome Engineering Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exosome Engineering Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exosome Engineering Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Exosome Engineering Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Loaded Cargos
Non-Cargo
Segmentation by Application:
Health Care Providers
Pharmaceutical & Biotechnology Companies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative Biostructure
Everzom
System Biosciences
Creative Biolabs
LipExoGen
Lifeasible
Exom
Sanbio BV
AEGLE Therapeutics
Aruna Bio, Inc.
Bio-Techne Corporation
Carmine Therapeutics, Inc.
Codiak BioSciences, Inc.
Fujifilm Holdings Corporation
Beckman Coulter

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Exosome Engineering Service 麻豆原创 Size (2020-2031)
2.1.2 Exosome Engineering Service 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Exosome Engineering Service by Country/Region (2020, 2024 & 2031)
2.2 Exosome Engineering Service Segment by Type
2.2.1 Loaded Cargos
2.2.2 Non-Cargo
2.3 Exosome Engineering Service 麻豆原创 Size by Type
2.3.1 Exosome Engineering Service 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Exosome Engineering Service 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Exosome Engineering Service Segment by Application
2.4.1 Health Care Providers
2.4.2 Pharmaceutical & Biotechnology Companies
2.4.3 Others
2.5 Exosome Engineering Service 麻豆原创 Size by Application
2.5.1 Exosome Engineering Service 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Exosome Engineering Service 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Exosome Engineering Service 麻豆原创 Size by Player
3.1 Exosome Engineering Service 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Exosome Engineering Service Revenue by Player (2020-2025)
3.1.2 Global Exosome Engineering Service Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Exosome Engineering Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Exosome Engineering Service by Region
4.1 Exosome Engineering Service 麻豆原创 Size by Region (2020-2025)
4.2 Global Exosome Engineering Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Exosome Engineering Service 麻豆原创 Size Growth (2020-2025)
4.4 APAC Exosome Engineering Service 麻豆原创 Size Growth (2020-2025)
4.5 Europe Exosome Engineering Service 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Exosome Engineering Service 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Exosome Engineering Service 麻豆原创 Size by Country (2020-2025)
5.2 Americas Exosome Engineering Service 麻豆原创 Size by Type (2020-2025)
5.3 Americas Exosome Engineering Service 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exosome Engineering Service 麻豆原创 Size by Region (2020-2025)
6.2 APAC Exosome Engineering Service 麻豆原创 Size by Type (2020-2025)
6.3 APAC Exosome Engineering Service 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Exosome Engineering Service 麻豆原创 Size by Country (2020-2025)
7.2 Europe Exosome Engineering Service 麻豆原创 Size by Type (2020-2025)
7.3 Europe Exosome Engineering Service 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Exosome Engineering Service by Region (2020-2025)
8.2 Middle East & Africa Exosome Engineering Service 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Exosome Engineering Service 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Exosome Engineering Service 麻豆原创 Forecast
10.1 Global Exosome Engineering Service Forecast by Region (2026-2031)
10.1.1 Global Exosome Engineering Service Forecast by Region (2026-2031)
10.1.2 Americas Exosome Engineering Service Forecast
10.1.3 APAC Exosome Engineering Service Forecast
10.1.4 Europe Exosome Engineering Service Forecast
10.1.5 Middle East & Africa Exosome Engineering Service Forecast
10.2 Americas Exosome Engineering Service Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Exosome Engineering Service Forecast
10.2.2 Canada 麻豆原创 Exosome Engineering Service Forecast
10.2.3 Mexico 麻豆原创 Exosome Engineering Service Forecast
10.2.4 Brazil 麻豆原创 Exosome Engineering Service Forecast
10.3 APAC Exosome Engineering Service Forecast by Region (2026-2031)
10.3.1 China Exosome Engineering Service 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Exosome Engineering Service Forecast
10.3.3 Korea 麻豆原创 Exosome Engineering Service Forecast
10.3.4 Southeast Asia 麻豆原创 Exosome Engineering Service Forecast
10.3.5 India 麻豆原创 Exosome Engineering Service Forecast
10.3.6 Australia 麻豆原创 Exosome Engineering Service Forecast
10.4 Europe Exosome Engineering Service Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Exosome Engineering Service Forecast
10.4.2 France 麻豆原创 Exosome Engineering Service Forecast
10.4.3 UK 麻豆原创 Exosome Engineering Service Forecast
10.4.4 Italy 麻豆原创 Exosome Engineering Service Forecast
10.4.5 Russia 麻豆原创 Exosome Engineering Service Forecast
10.5 Middle East & Africa Exosome Engineering Service Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Exosome Engineering Service Forecast
10.5.2 South Africa 麻豆原创 Exosome Engineering Service Forecast
10.5.3 Israel 麻豆原创 Exosome Engineering Service Forecast
10.5.4 Turkey 麻豆原创 Exosome Engineering Service Forecast
10.6 Global Exosome Engineering Service Forecast by Type (2026-2031)
10.7 Global Exosome Engineering Service Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Exosome Engineering Service Forecast
11 Key Players Analysis
11.1 Creative Biostructure
11.1.1 Creative Biostructure Company Information
11.1.2 Creative Biostructure Exosome Engineering Service Product Offered
11.1.3 Creative Biostructure Exosome Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Creative Biostructure Main Business Overview
11.1.5 Creative Biostructure Latest Developments
11.2 Everzom
11.2.1 Everzom Company Information
11.2.2 Everzom Exosome Engineering Service Product Offered
11.2.3 Everzom Exosome Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Everzom Main Business Overview
11.2.5 Everzom Latest Developments
11.3 System Biosciences
11.3.1 System Biosciences Company Information
11.3.2 System Biosciences Exosome Engineering Service Product Offered
11.3.3 System Biosciences Exosome Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 System Biosciences Main Business Overview
11.3.5 System Biosciences Latest Developments
11.4 Creative Biolabs
11.4.1 Creative Biolabs Company Information
11.4.2 Creative Biolabs Exosome Engineering Service Product Offered
11.4.3 Creative Biolabs Exosome Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Creative Biolabs Main Business Overview
11.4.5 Creative Biolabs Latest Developments
11.5 LipExoGen
11.5.1 LipExoGen Company Information
11.5.2 LipExoGen Exosome Engineering Service Product Offered
11.5.3 LipExoGen Exosome Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 LipExoGen Main Business Overview
11.5.5 LipExoGen Latest Developments
11.6 Lifeasible
11.6.1 Lifeasible Company Information
11.6.2 Lifeasible Exosome Engineering Service Product Offered
11.6.3 Lifeasible Exosome Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Lifeasible Main Business Overview
11.6.5 Lifeasible Latest Developments
11.7 Exom
11.7.1 Exom Company Information
11.7.2 Exom Exosome Engineering Service Product Offered
11.7.3 Exom Exosome Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Exom Main Business Overview
11.7.5 Exom Latest Developments
11.8 Sanbio BV
11.8.1 Sanbio BV Company Information
11.8.2 Sanbio BV Exosome Engineering Service Product Offered
11.8.3 Sanbio BV Exosome Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Sanbio BV Main Business Overview
11.8.5 Sanbio BV Latest Developments
11.9 AEGLE Therapeutics
11.9.1 AEGLE Therapeutics Company Information
11.9.2 AEGLE Therapeutics Exosome Engineering Service Product Offered
11.9.3 AEGLE Therapeutics Exosome Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 AEGLE Therapeutics Main Business Overview
11.9.5 AEGLE Therapeutics Latest Developments
11.10 Aruna Bio, Inc.
11.10.1 Aruna Bio, Inc. Company Information
11.10.2 Aruna Bio, Inc. Exosome Engineering Service Product Offered
11.10.3 Aruna Bio, Inc. Exosome Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Aruna Bio, Inc. Main Business Overview
11.10.5 Aruna Bio, Inc. Latest Developments
11.11 Bio-Techne Corporation
11.11.1 Bio-Techne Corporation Company Information
11.11.2 Bio-Techne Corporation Exosome Engineering Service Product Offered
11.11.3 Bio-Techne Corporation Exosome Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Bio-Techne Corporation Main Business Overview
11.11.5 Bio-Techne Corporation Latest Developments
11.12 Carmine Therapeutics, Inc.
11.12.1 Carmine Therapeutics, Inc. Company Information
11.12.2 Carmine Therapeutics, Inc. Exosome Engineering Service Product Offered
11.12.3 Carmine Therapeutics, Inc. Exosome Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Carmine Therapeutics, Inc. Main Business Overview
11.12.5 Carmine Therapeutics, Inc. Latest Developments
11.13 Codiak BioSciences, Inc.
11.13.1 Codiak BioSciences, Inc. Company Information
11.13.2 Codiak BioSciences, Inc. Exosome Engineering Service Product Offered
11.13.3 Codiak BioSciences, Inc. Exosome Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Codiak BioSciences, Inc. Main Business Overview
11.13.5 Codiak BioSciences, Inc. Latest Developments
11.14 Fujifilm Holdings Corporation
11.14.1 Fujifilm Holdings Corporation Company Information
11.14.2 Fujifilm Holdings Corporation Exosome Engineering Service Product Offered
11.14.3 Fujifilm Holdings Corporation Exosome Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Fujifilm Holdings Corporation Main Business Overview
11.14.5 Fujifilm Holdings Corporation Latest Developments
11.15 Beckman Coulter
11.15.1 Beckman Coulter Company Information
11.15.2 Beckman Coulter Exosome Engineering Service Product Offered
11.15.3 Beckman Coulter Exosome Engineering Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Beckman Coulter Main Business Overview
11.15.5 Beckman Coulter Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.